(19)
(11) EP 1 729 740 A2

(12)

(88) Date of publication A3:
05.01.2006

(43) Date of publication:
13.12.2006 Bulletin 2006/50

(21) Application number: 05733181.1

(22) Date of filing: 01.04.2005
(51) International Patent Classification (IPC): 
A61K 9/20(2006.01)
A61K 9/48(2006.01)
A61K 9/22(2006.01)
A61K 9/52(2006.01)
(86) International application number:
PCT/US2005/011032
(87) International publication number:
WO 2005/097079 (20.10.2005 Gazette 2005/42)
(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU MC NL PL PT RO SE SI SK TR
Designated Extension States:
AL BA HR LV MK YU

(30) Priority: 02.04.2004 US 815930
02.04.2004 US 815926
02.04.2004 US 815924
02.04.2004 US 815929

(71) Applicant: Impax Laboratories, Inc.
Haywood, CA 94544 (US)

(72) Inventors:
  • HAN, Chien-Hsuan
    Sunnyvale, California 94087 (US)
  • HSU, Ann
    Los Altos Hills, California 94022 (US)
  • HSU, Larry
    Los Altos Hills, California 94022 (US)
  • HSIAO, Charles
    Pleasanton, California 94566 (US)
  • TENG, Ching-Ling Diana
    Fremont, California 94536 (US)

(74) Representative: Baldock, Sharon Claire 
Boult Wade Tennant Verulam Gardens 70 Gray's Inn Road
London WC1X 8BT
London WC1X 8BT (GB)

   


(54) PHARMACEUTICAL DOSAGE FORMS HAVING IMMEDIATE RELEASE AND/OR CONTROLLED RELEASE PROPERTIES THAT CONTAIN A GABA<SB>B</SB> RECEPTOR AGONIST